Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dolby Laboratories, Inc.DLB · Entity 2518 | EVP, Gen. Counsel & Secretary | September 15, 2026 | September 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dolby Laboratories, Inc.
Report date September 15, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 119,024 |
Reported balance
After 2026-09-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-15 · Grant · Acquired 48,076 · Balance 119,024 F1: Award represents a total of 48,076 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 100% of the units shall vest on September 15, 2028, subject to the Reporting Person continuing to be a service provider through such date. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2: Shares held following the reported transactions include 101,712 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F3: Shares include 385 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Award represents a total of 48,076 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 100% of the units shall vest on September 15, 2028, subject to the Reporting Person continuing to be a service provider through such date. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting.
F2: Shares held following the reported transactions include 101,712 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F3: Shares include 385 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2020 Filed Dec 17, 2020 19:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 7,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-064236 · doc4.xml · derivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,136 Underlying: Class A Common Stock · 7,136 shares Expires not disclosed F8 · derivative.exercise_price: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F8 · derivative.exercise_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F8 · derivative.expiration_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 19:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 14,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-064236 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,962 F3 · acquired: Award represents a total of 14,272 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2020. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F4 · balance_after: Shares held following the reported transactions include 40,722 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 19:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 3,348 | $90.86 | $304,199.28 |
DisclosureSEC source: 0001209191-20-064236 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,690 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 26,450 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 16:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,582 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-20-057140 · doc4.xml · derivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,118 Underlying: Class A Common Stock · 1,582 shares Expires 2023-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This performance-based stock option award was granted for a total of 26,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2019 was at 95% of target, or 24,700 shares. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 16:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 23,418 | $0.00 Strike: $42.98 | $0.00 |
DisclosureSEC source: 0001209191-20-057140 · doc4.xml · derivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 23,418 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 75,212 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 16:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,582 | $80.00 | $126,563.01 |
DisclosureSEC source: 0001209191-20-057140 · doc4.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,038 F3 · price: The shares were sold in multiple transactions at prices ranging from $80.00 to $80.01, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 16:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 1,582 | $45.50 | $71,981.00 |
DisclosureSEC source: 0001209191-20-057140 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 16:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 23,418 | $80.00 | $1,873,458.73 |
DisclosureSEC source: 0001209191-20-057140 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,038 F2 · price: The shares were sold in multiple transactions at prices ranging from $80.00 to $80.02, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 16:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 23,418 | $42.98 | $1,006,505.64 |
DisclosureSEC source: 0001209191-20-057140 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 16:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $42.98 | $0.00 |
DisclosureSEC source: 0001209191-20-056637 · doc4.xml · derivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,418 Underlying: Class A Common Stock · 25,000 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 75,212 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 16:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 25,000 | $76.00 | $1,900,007.50 |
DisclosureSEC source: 0001209191-20-056637 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,038 F3 · price: The shares were sold in multiple transactions at prices ranging from $76.00 to $76.075, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest F2 · balance_after: Shares include 387 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2020. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 16:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 25,000 | $42.98 | $1,074,500.00 |
DisclosureSEC source: 0001209191-20-056637 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest F2 · balance_after: Shares include 387 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2020. Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 16:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $42.98 | $0.00 |
DisclosureSEC source: 0001209191-20-011099 · doc4.xml · derivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,418 Underlying: Class A Common Stock · 20,000 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted for a total of 75,212 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 16:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 20,000 | $73.00 | $1,460,000.00 |
DisclosureSEC source: 0001209191-20-011099 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,651 F1 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 16:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 20,000 | $42.98 | $859,600.00 |
DisclosureSEC source: 0001209191-20-011099 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 20:01 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 29,821 | $0.00 Strike: $37.35 | $0.00 |
DisclosureSEC source: 0001209191-20-008135 · doc4.xml · derivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 29,821 shares Expires 2023-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 74,037 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2013, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 20:01 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,794 | $0.00 Strike: $42.98 | $0.00 |
DisclosureSEC source: 0001209191-20-008135 · doc4.xml · derivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,418 Underlying: Class A Common Stock · 6,794 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 75,212 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 20:01 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 29,821 | $71.99 | $2,146,942.02 |
DisclosureSEC source: 0001209191-20-008135 · doc4.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,651 F3 · price: The shares were sold in multiple transactions at prices ranging from $71.66 to $72.25, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 20:01 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 29,821 | $37.35 | $1,113,814.35 |
DisclosureSEC source: 0001209191-20-008135 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,472 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 20:01 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 6,794 | $72.02 | $489,293.69 |
DisclosureSEC source: 0001209191-20-008135 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,651 F2 · price: The shares were sold in multiple transactions at prices ranging from $71.763 to $72.25, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 20:01 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 6,794 | $42.98 | $292,006.12 |
DisclosureSEC source: 0001209191-20-008135 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 20:31 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 38,176 | $0.00 Strike: $37.35 | $0.00 |
DisclosureSEC source: 0001209191-20-007343 · doc4.xml · derivative · entry 7 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,821 Underlying: Class A Common Stock · 38,176 shares Expires 2023-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted for a total of 74,037 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2013, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 20:31 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,209 | $0.00 Strike: $33.15 | $0.00 |
DisclosureSEC source: 0001209191-20-007343 · doc4.xml · derivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,209 shares Expires 2025-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 50,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2015, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 20:31 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 38,176 | $71.94 | $2,746,308.91 |
DisclosureSEC source: 0001209191-20-007343 · doc4.xml · nonDerivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,651 F4 · price: The shares were sold in multiple transactions at prices ranging from $71.63 to $72.17, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 20:31 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 38,176 | $37.35 | $1,425,873.60 |
DisclosureSEC source: 0001209191-20-007343 · doc4.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,827 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 20:31 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 5,209 | $72.00 | $375,061.54 |
DisclosureSEC source: 0001209191-20-007343 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,651 F3 · price: The shares were sold in multiple transactions at prices ranging from $71.65 to $72.16, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 20:31 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 5,209 | $33.15 | $172,678.35 |
DisclosureSEC source: 0001209191-20-007343 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,860 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 20:31 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 6,615 | $72.03 | $476,451.99 |
DisclosureSEC source: 0001209191-20-007343 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,651 F1 · price: The shares were sold in multiple transactions at prices ranging from $71.65 to $72.14, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 33,200 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| December 17, 2019 Filed Dec 18, 2019 21:38 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,612 | $68.40 | $110,260.80 |
DisclosureSEC source: 0001209191-19-061236 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,266 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F5 · balance_after: Shares held following the reported transactions include 33,200 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:38 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $68.40 | $0.00 |
DisclosureSEC source: 0001209191-19-061236 · doc4.xml · derivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Class A Common Stock · 60,000 shares Expires 2029-12-16 F7 · derivative.exercise_date: This option was granted for a total of 60,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 16, 2019, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:38 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 6,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-061236 · doc4.xml · derivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,600 Underlying: Class A Common Stock · 6,600 shares Expires not disclosed F6 · derivative.exercise_price: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 16, 2019 and ending December 13, 2022. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F6 · derivative.exercise_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 16, 2019 and ending December 13, 2022. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F6 · derivative.expiration_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 16, 2019 and ending December 13, 2022. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:38 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 13,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-061236 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,878 F3 · acquired: Award represents a total of 13,200 restricted stock units granted under the terms of the Issuer's 2005 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 16, 2019. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F4 · balance_after: Shares held following the reported transactions include 36,450 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:38 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 4,898 | $67.75 | $331,839.50 |
DisclosureSEC source: 0001209191-19-061236 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,678 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 23,250 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 19:18 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,040 | $0.00 Strike: $37.35 | $0.00 |
DisclosureSEC source: 0001209191-19-044359 · doc4.xml · derivative · entry 12 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,997 Underlying: Class A Common Stock · 6,040 shares Expires 2023-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 74,037 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2013, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 19:18 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,460 | $0.00 Strike: $33.15 | $0.00 |
DisclosureSEC source: 0001209191-19-044359 · doc4.xml · derivative · entry 11 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,460 shares Expires 2022-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This performance-based stock option award was granted for a total of 25,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 125% of target, or 31,250 shares. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 19:18 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 6,040 | $67.73 | $409,089.20 |
DisclosureSEC source: 0001209191-19-044359 · doc4.xml · nonDerivative · entry 8 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,576 F1 · balance_after: Shares held following the reported transactions include 33,125 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 19:18 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 6,040 | $37.35 | $225,594.00 |
DisclosureSEC source: 0001209191-19-044359 · doc4.xml · nonDerivative · entry 7 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,125 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 19:18 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,460 | $67.73 | $98,885.80 |
DisclosureSEC source: 0001209191-19-044359 · doc4.xml · nonDerivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,576 F1 · balance_after: Shares held following the reported transactions include 33,125 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 19:18 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 1,460 | $33.15 | $48,399.00 |
DisclosureSEC source: 0001209191-19-044359 · doc4.xml · nonDerivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,125 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 19:18 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 29,790 | $0.00 Strike: $33.15 | $0.00 |
DisclosureSEC source: 0001209191-19-044359 · doc4.xml · derivative · entry 10 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,460 Underlying: Class A Common Stock · 29,790 shares Expires 2022-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This performance-based stock option award was granted for a total of 25,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 125% of target, or 31,250 shares. Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 19:18 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,210 | $0.00 Strike: $33.15 | $0.00 |
DisclosureSEC source: 0001209191-19-044359 · doc4.xml · derivative · entry 9 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,209 Underlying: Class A Common Stock · 20,210 shares Expires 2025-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 50,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2015, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 19:18 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 29,790 | $67.50 | $2,010,825.00 |
DisclosureSEC source: 0001209191-19-044359 · doc4.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,576 F1 · balance_after: Shares held following the reported transactions include 33,125 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 19:18 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 29,790 | $33.15 | $987,538.50 |
DisclosureSEC source: 0001209191-19-044359 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,125 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 19:18 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 20,210 | $67.50 | $1,364,175.00 |
DisclosureSEC source: 0001209191-19-044359 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,576 F1 · balance_after: Shares held following the reported transactions include 33,125 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 19:18 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 20,210 | $33.15 | $669,961.50 |
DisclosureSEC source: 0001209191-19-044359 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,786 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,125 restricted stock units, which are subject to forfeiture until they vest F2 · balance_after: Shares include 397 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2019. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 19:08 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,063 | $0.00 Strike: $33.15 | $0.00 |
DisclosureSEC source: 0001209191-19-013222 · doc4.xml · derivative · entry 10 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,419 Underlying: Class A Common Stock · 5,063 shares Expires 2025-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted for a total of 50,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2015, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 19:08 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 5,063 | $65.00 | $329,095.00 |
DisclosureSEC source: 0001209191-19-013222 · doc4.xml · nonDerivative · entry 7 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,179 F2 · balance_after: Shares held following the reported transactions include 33,125 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 19:08 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 5,063 | $33.15 | $167,838.45 |
DisclosureSEC source: 0001209191-19-013222 · doc4.xml · nonDerivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Shares held following the reported transactions include 33,125 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:08 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 19,518 | $0.00 Strike: $33.15 | $0.00 |
DisclosureSEC source: 0001209191-19-013222 · doc4.xml · derivative · entry 9 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,482 Underlying: Class A Common Stock · 19,518 shares Expires 2025-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted for a total of 50,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2015, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:08 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,919 | $0.00 Strike: $30.49 | $0.00 |
DisclosureSEC source: 0001209191-19-013222 · doc4.xml · derivative · entry 8 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,919 shares Expires 2022-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 61,700 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 21, 2012, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.